Cargando…

Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients’ Outcome; a Cross-sectional Study

INTRODUCTION:  Despite the increasing vaccination coverage, COVID-19 is still a concern. With the limited health care capacity, early risk stratification is crucial to identify patients who should be prioritized for optimal management. The present study investigates whether on-admission lactate dehy...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Nafiseh, Tabatabaei, Fatemeh-sadat, Azimi, Amirali, Faraji, Neda, Akbarpour, Samaneh, Dianatkhah, Mehrnoush, Moghaddas, Azadeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397596/
https://www.ncbi.nlm.nih.gov/pubmed/36033986
http://dx.doi.org/10.22037/aaem.v10i1.1646
_version_ 1784772155374829568
author Alizadeh, Nafiseh
Tabatabaei, Fatemeh-sadat
Azimi, Amirali
Faraji, Neda
Akbarpour, Samaneh
Dianatkhah, Mehrnoush
Moghaddas, Azadeh
author_facet Alizadeh, Nafiseh
Tabatabaei, Fatemeh-sadat
Azimi, Amirali
Faraji, Neda
Akbarpour, Samaneh
Dianatkhah, Mehrnoush
Moghaddas, Azadeh
author_sort Alizadeh, Nafiseh
collection PubMed
description INTRODUCTION:  Despite the increasing vaccination coverage, COVID-19 is still a concern. With the limited health care capacity, early risk stratification is crucial to identify patients who should be prioritized for optimal management. The present study investigates whether on-admission lactate dehydrogenase to albumin ratio (LAR) can be used to predict COVID-19 outcomes. METHODS: This retrospective cross-sectional study evaluated hospitalized COVID-19 patients in an academic referral center in Iran from May 2020 to October 2020. The area under the receiver operating characteristic (ROC) curve (AUC) was used to evaluate the value of LAR in the prediction of mortality. The Yuden index was used to find the optimal cut-off of LAR to distinguish severity. Patients were classified into three groups (LAR tertiles), first: LAR<101.46, second: 101.46≤LAR< 148.78, and third group: LAR≥148.78. Logistic regression analysis was used to identify the association between tertiles of LAR, as well as the relationship between each one-unit increase in LAR with mortality and ICU admission in three models, based on potential confounding variables RESULTS: A total of 477 patients were included. Among all patients, 100 patients (21%) died, and 121 patients (25.4%) were admitted to intensive care unit (ICU). In the third group, the risk of mortality and ICU admission increased 7.78 times (OR=7.78, CI: 3.95-15.26; p <0.0001) and 4.49 times (OR=4.49, CI: 2.01-9.04; p <0.0001), respectively, compared to the first group. The AUC of LAR for prediction of mortality was 0.768 (95% CI 0.69- 0.81). LAR ≥ 136, with the sensitivity and specificity of 72% (95%CI: 62.1-80.5) and 70% (95%CI: 64.9-74.4), respectively, was the optimal cut-off value for predicting mortality. CONCLUSION: High LAR was associated with higher odds of COVID-19 mortality, ICU admission, and length of hospitalization. On-admission LAR levels might help health care workers identify critical patients early on.
format Online
Article
Text
id pubmed-9397596
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Shahid Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-93975962022-08-26 Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients’ Outcome; a Cross-sectional Study Alizadeh, Nafiseh Tabatabaei, Fatemeh-sadat Azimi, Amirali Faraji, Neda Akbarpour, Samaneh Dianatkhah, Mehrnoush Moghaddas, Azadeh Arch Acad Emerg Med Original Article INTRODUCTION:  Despite the increasing vaccination coverage, COVID-19 is still a concern. With the limited health care capacity, early risk stratification is crucial to identify patients who should be prioritized for optimal management. The present study investigates whether on-admission lactate dehydrogenase to albumin ratio (LAR) can be used to predict COVID-19 outcomes. METHODS: This retrospective cross-sectional study evaluated hospitalized COVID-19 patients in an academic referral center in Iran from May 2020 to October 2020. The area under the receiver operating characteristic (ROC) curve (AUC) was used to evaluate the value of LAR in the prediction of mortality. The Yuden index was used to find the optimal cut-off of LAR to distinguish severity. Patients were classified into three groups (LAR tertiles), first: LAR<101.46, second: 101.46≤LAR< 148.78, and third group: LAR≥148.78. Logistic regression analysis was used to identify the association between tertiles of LAR, as well as the relationship between each one-unit increase in LAR with mortality and ICU admission in three models, based on potential confounding variables RESULTS: A total of 477 patients were included. Among all patients, 100 patients (21%) died, and 121 patients (25.4%) were admitted to intensive care unit (ICU). In the third group, the risk of mortality and ICU admission increased 7.78 times (OR=7.78, CI: 3.95-15.26; p <0.0001) and 4.49 times (OR=4.49, CI: 2.01-9.04; p <0.0001), respectively, compared to the first group. The AUC of LAR for prediction of mortality was 0.768 (95% CI 0.69- 0.81). LAR ≥ 136, with the sensitivity and specificity of 72% (95%CI: 62.1-80.5) and 70% (95%CI: 64.9-74.4), respectively, was the optimal cut-off value for predicting mortality. CONCLUSION: High LAR was associated with higher odds of COVID-19 mortality, ICU admission, and length of hospitalization. On-admission LAR levels might help health care workers identify critical patients early on. Shahid Beheshti University of Medical Sciences 2022-08-15 /pmc/articles/PMC9397596/ /pubmed/36033986 http://dx.doi.org/10.22037/aaem.v10i1.1646 Text en https://creativecommons.org/licenses/by-nc/3.0/This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0) https://creativecommons.org/licenses/by-nc/3.0/.
spellingShingle Original Article
Alizadeh, Nafiseh
Tabatabaei, Fatemeh-sadat
Azimi, Amirali
Faraji, Neda
Akbarpour, Samaneh
Dianatkhah, Mehrnoush
Moghaddas, Azadeh
Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients’ Outcome; a Cross-sectional Study
title Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients’ Outcome; a Cross-sectional Study
title_full Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients’ Outcome; a Cross-sectional Study
title_fullStr Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients’ Outcome; a Cross-sectional Study
title_full_unstemmed Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients’ Outcome; a Cross-sectional Study
title_short Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients’ Outcome; a Cross-sectional Study
title_sort lactate dehydrogenase to albumin ratio as a predictive factor of covid-19 patients’ outcome; a cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397596/
https://www.ncbi.nlm.nih.gov/pubmed/36033986
http://dx.doi.org/10.22037/aaem.v10i1.1646
work_keys_str_mv AT alizadehnafiseh lactatedehydrogenasetoalbuminratioasapredictivefactorofcovid19patientsoutcomeacrosssectionalstudy
AT tabatabaeifatemehsadat lactatedehydrogenasetoalbuminratioasapredictivefactorofcovid19patientsoutcomeacrosssectionalstudy
AT azimiamirali lactatedehydrogenasetoalbuminratioasapredictivefactorofcovid19patientsoutcomeacrosssectionalstudy
AT farajineda lactatedehydrogenasetoalbuminratioasapredictivefactorofcovid19patientsoutcomeacrosssectionalstudy
AT akbarpoursamaneh lactatedehydrogenasetoalbuminratioasapredictivefactorofcovid19patientsoutcomeacrosssectionalstudy
AT dianatkhahmehrnoush lactatedehydrogenasetoalbuminratioasapredictivefactorofcovid19patientsoutcomeacrosssectionalstudy
AT moghaddasazadeh lactatedehydrogenasetoalbuminratioasapredictivefactorofcovid19patientsoutcomeacrosssectionalstudy